MPS Powered by Eureka

Anti-Cancer Agents in Medicinal Chemistry

ISSN: 1871-5206 (Print)
eISSN: 1875-5992 (Online)

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth/mini-reviews and guest-edited issues written by leaders in the field covering a range of current topics in oncology and medicinal chemistry. The journal considers high-quality reviews and research papers for publication. Scientific areas within the scope of the journal include:

  • Medicinal chemistry, prevention, diagnosis, and treatment of malignant diseases
  • In silico studies of drug-target interaction in anti-cancer drug assessment
  • Underlying biology and medicinal chemistry strategies for anti-cancer drug synthesis and development
  • New drugs related to a specific target or target class for anticancer drugs
  • Drug repositioning in cancer
  • Clinical cancer research
  • Radiotherapy and systemic treatment of cancer
  • Other related areas

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.

Special Issues With Active Call for Papers

Submission closes on: Sep 23, 2024
Signaling and enzymatic modulators in cancer treatment

Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several types of cancers. However, intrinsic or acquired resistance and metastasis are still major obstacles to a successful cure. Outstanding progress in genetics and molecular biology... see more

Submission closes on: Sep 16, 2024
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs

Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase activity where every division of cells shortens the length of telomeres at chromosomal ends. In somatic cells, when a critical length of telomeres reaches they... see more